Liso-Cel in Relapsed/Refractory Marginal Zone Lymphoma

Clinical trial NCT07777120 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07777120
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Marginal Zone Lymphoma

Start date: 2026-03-24
Primary completion: 2048-03-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.